世界の末梢動脈疾患市場2025

◆英語タイトル:Global Peripheral Artery Disease Market Research Report—Forecast till 2025
◆商品コード:MRF20OT025
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2020年2月24日
◆ページ数:137
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥480,600見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Market Research Future社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、末梢動脈疾患の世界市場について調査・分析し、エグゼクティブサマリー、イントロダクション、調査手法、市場動向、市場要因分析、治療種類別市場規模(機器治療、薬物治療)、エンドユーザー別市場規模(病院・診療所、外来手術センター)、地域別市場規模、競争状況、企業概要などの項目を掲載しています。
・エグゼクティブサマリー
・イントロダクション
・調査手法
・市場動向
・市場要因分析
・末梢動脈疾患の世界市場規模:治療種類別(機器治療、薬物治療)
・末梢動脈疾患の世界市場規模:エンドユーザー別(病院・診療所、外来手術センター)
・末梢動脈疾患の世界市場規模:地域別
・競争状況
・企業概要
【レポートの概要】

Global Peripheral Artery Disease Market Research Report—Forecast till 2025

[Market Synopsis]
The Global Peripheral Artery Disease Market is accounted to register a CAGR of 4.84% to reach USD 23,624.01 Million during the forecast period. The disorder of blood vessels located outside the brain and heart is known as a peripheral artery. The reasons PAD are occurs when plaque builds up in the arteries that carry blood to the head, organs, and limb because of fat, cholesterol, calcium, fibrous tissue, and other substances in the blood. The growing geriatric population and increasing prevalence of peripheral artery disorder with rising product approvals are driving the market growth. Additionally, the increasing prevalence of diabetes is also expected to drive the global market.
The global peripheral artery disease market is estimated to reach a steady growth during the forecast period owing to focusing on product launches, approvals, and partnerships to gain market dominance and keep their product updated and in demand. However, the global market growth product recalls and failures are expected to restrain market growth.

[Market Segmentation]
The Global Peripheral Artery Disease Market has been categorized based on Treatment Type and End User. By treatment type, the global market has been segregated into devices and drugs. Devices are further classified into angioplasty balloon, angioplasty stents (stenting), catheters, plaque modification devices (atherectomy), hemodynamic flow alteration devices, and others. Drugs are further sub-divided into lipid-lowering drugs, blood pressure-lowering drugs, glucose regulating drugs, and blood clot preventing drugs. The global peripheral artery disease market, by the end-user, has been categorized as hospitals and clinics, ambulatory surgery centers, and others.

[Regional Analysis]
The geographical analysis of the global peripheral artery disease market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The Americas were likely to drive the largest market of the global peripheral artery disease market the region was contributed to the largest market share in 2018. The regional market growth is attributed to the growing prevalence of diabetes, increasing healthcare expenditure, and rising cases of obesity. However, the adoption of modern lifestyle like dietary habits, alcohol consumption, lack of physical activities are inclining individuals to peripheral artery disease and is driving the market growth.
Europe is accounted for the second-largest market for peripheral artery disease with Western Europe, holding the largest market share. The European market is expected to register a significant growth rate during the forecast period owing to rising cardiovascular diseases and increasing cigarette smoking population. Moreover, the rising geriatric population in the European Union is propelling the growth of the peripheral artery disease market in Europe.
Asia-Pacific is expected to anticipate the highest market growth potential over the forecast period owing to the growing patient pool and increasing technological advancements.

[Major Players]
The Major Players in the Global Peripheral Artery Disease Market are Koninklijke Philips NV (Netherlands), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Bayer AG (Germany), Boston Scientific Corporation (US), Becton, Dickinson, and Company (BD) (US), Terumo Medical Corporation (Japan ), Biotronik (Germany), Cardinal Health (US), and others.

[COVID 19 Impacts]
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations and many other useful insights.

【レポートの目次】

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 15
1.1.1 MARKET SYNOPSIS 15
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 16
2.2 RESEARCH OBJECTIVE 16
2.3 LIST OF ASSUMPTIONS 16
3 RESEARCH METHODOLOGY
3.1.1 OVERVIEW 18
3.2 DATA MINING 18
3.3 SECONDARY RESEARCH 19
3.4 PRIMARY RESEARCH 20
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.5 FORECASTING TECHNIQUES 21
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 24
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 RISING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN THE PREVALENCE OF
PERIPHERAL ARTERY DISEASES 26
4.2.2 PRODUCT LAUNCH AND TECHNOLOGICAL ADVANCEMENT 26
4.2.3 INCREASING CASES OF DIABETES 27
4.2.4 DRIVERS IMPACT ANALYSIS 27
4.3 RESTRAINTS 28
4.3.1 PRODUCT RECALLS 28
4.3.2 RESTRAINTS IMPACT ANALYSIS 28
4.4 OPPORTUNITIES 28
4.4.1 ENTRY OF MARKET PLAYERS INTO EMERGING ECONOMIES 28
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 29
5.1.1 THREAT OF NEW ENTRANTS 30
5.1.2 BARGAINING POWER OF SUPPLIERS 30
5.1.3 THREAT OF SUBSTITUTES 30
5.1.4 BARGAINING POWER OF BUYERS 30
5.1.5 INTENSITY OF RIVALRY 30
5.2 VALUE CHAIN ANALYSIS 31
5.2.1 R&D AND DESIGNING 32
5.2.2 MANUFACTURING 32
5.2.3 DISTRIBUTION 32
5.2.4 MARKETING & SALES 32
5.2.5 POST-SALES MONITORING 32
6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE
6.1 OVERVIEW 33
6.2 DEVICES 34
6.2.1 ANGIOPLASTY BALLOON 36
6.2.2 ANGIOPLASTY STENTS (STENTING) 37
6.2.3 CATHETERS 37
6.2.4 PLAQUE MODIFICATION DEVICES (ATHERECTOMY) 38
6.2.5 HEMODYNAMIC FLOW ALTERATION DEVICES 38
6.3 DRUGS 39
6.3.1 LIPID-LOWERING DRUGS 40
6.3.2 BLOOD PRESSURE LOWERING DRUGS 41
6.3.3 GLUCOSE REGULATING DRUGS 41
6.3.4 BLOOD CLOT PREVENTING DRUGS 42
7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER
7.1 OVERVIEW 43
7.1.1 HOSPITALS AND CLINICS 45
7.1.2 AMBULATORY SURGERY CENTERS 45
8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION
8.1 OVERVIEW 46
8.2 AMERICAS 47
8.2.1 NORTH AMERICA 50
8.2.2 LATIN AMERICA 57
8.3 EUROPE 59
8.3.1 WESTERN EUROPE 62
8.3.2 EASTERN EUROPE 78
8.4 ASIA-PACIFIC 80
8.4.1 CHINA 83
8.4.2 JAPAN 85
8.4.3 INDIA 87
8.4.4 AUSTRALIA 89
8.4.5 SOUTH KOREA 91
8.4.6 REST OF ASIA-PACIFIC 93
8.5 MIDDLE EAST & AFRICA 95
8.5.1 MIDDLE EAST 99
8.5.2 AFRICA 101
9 COMPETITIVE LANDSCAPE: GLOBAL PERIPHERAL ARTERY DISEASE MARKET
9.1 OVERVIEW 103
9.2 COMPETITIVE ANALYSIS 103
10 COMPANY PROFILES
10.1 KONINKLIJKE PHILIPS NV 104
10.1.1 COMPANY OVERVIEW 104
10.1.2 FINANCIAL OVERVIEW 105
10.1.3 PRODUCTS/SERVICES OFFERED 106
10.1.4 KEY DEVELOPMENTS 106
10.1.5 SWOT ANALYSIS 107
10.1.6 KEY STRATEGIES 107
10.2 B. BRAUN MELSUNGEN AG 108
10.2.1 COMPANY OVERVIEW 108
10.2.2 FINANCIAL OVERVIEW 109
10.2.3 PRODUCTS/SERVICES OFFERED 109
10.2.4 KEY DEVELOPMENTS 110
10.2.5 SWOT ANALYSIS 110
10.2.6 KEY STRATEGIES 110
10.3 COOK 111
10.3.1 COMPANY OVERVIEW 111
10.3.2 FINANCIAL OVERVIEW 111
10.3.3 PRODUCTS/SERVICES OFFERED 111
10.3.4 KEY DEVELOPMENTS 111
10.3.5 SWOT ANALYSIS 112
10.3.6 KEY STRATEGIES 112
10.4 MEDTRONIC 113
10.4.1 COMPANY OVERVIEW 113
10.4.2 FINANCIAL OVERVIEW 114
10.4.3 PRODUCTS/SERVICES OFFERED 115
10.4.4 MEDTRONIC: KEY DEVELOPMENTS 115
10.4.5 SWOT ANALYSIS 116
10.4.6 KEY STRATEGIES 116
10.5 BAYER AG 117
10.5.1 COMPANY OVERVIEW 117
10.5.2 FINANCIAL OVERVIEW 118
10.5.3 PRODUCTS/SERVICES OFFERED 118
10.5.4 KEY DEVELOPMENTS 119
10.5.5 SWOT ANALYSIS 119
10.5.6 KEY STRATEGIES 119
10.6 BOSTON SCIENTIFIC CORPORATION 120
10.6.1 COMPANY OVERVIEW 120
10.6.2 FINANCIAL OVERVIEW 121
10.6.3 PRODUCTS/SERVICES OFFERED 122
10.6.4 KEY DEVELOPMENTS 122
10.6.5 SWOT ANALYSIS 123
10.6.6 KEY STRATEGIES 123
10.7 BECTON, DICKINSON AND COMPANY 124
10.7.1 COMPANY OVERVIEW 124
10.7.2 FINANCIAL OVERVIEW 125
10.7.3 PRODUCTS/SERVICES OFFERED 125
10.7.4 KEY DEVELOPMENTS 126
10.7.5 SWOT ANALYSIS 126
10.7.6 KEY STRATEGIES 126

10.8 TERUMO MEDICAL CORPORATION 127
10.8.1 COMPANY OVERVIEW 127
10.8.2 FINANCIAL OVERVIEW 128
10.8.3 PRODUCTS OFFERED 128
10.8.4 KEY DEVELOPMENTS 129
10.8.5 SWOT ANALYSIS 129
10.8.6 KEY STRATEGIES 129
10.9 BIOTRONIK 130
10.9.1 COMPANY OVERVIEW 130
10.9.2 FINANCIAL OVERVIEW 130
10.9.3 PRODUCTS OFFERED 130
10.9.4 KEY DEVELOPMENTS 131
10.9.5 SWOT ANALYSIS 132
10.9.6 KEY STRATEGIES 132
10.10 CARDINAL HEALTH 133
10.10.1 COMPANY OVERVIEW 133
10.10.2 FINANCIAL OVERVIEW 134
10.10.3 PRODUCTS OFFERED 135
10.10.4 KEY DEVELOPMENTS 135
10.10.5 SWOT ANALYSIS 136
10.10.6 KEY STRATEGIES 136
11 APPENDIX
11.1 REFERENCES 137
11.2 RELATED REPORTS 137

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS 16
TABLE 2 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 34
TABLE 3 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 36
TABLE 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR ANGIOPLASTY BALLOON, BY REGION, 2016–2025 (USD MILLION) 36
TABLE 5 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR ANGIOPLASTY STENTS (STENTING), BY REGION,
2016–2025 (USD MILLION) 37
TABLE 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR CATHETERS, BY REGION, 2016–2025 (USD MILLION) 37
TABLE 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR PLAQUE MODIFICATION DEVICES (ATHERECTOMY), BY REGION,
2016–2025 (USD MILLION) 38
TABLE 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION,
2016–2025 (USD MILLION) 38
TABLE 9 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 40
TABLE 10 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR LIPID-LOWERING DRUGS, BY REGION, 2016–2025 (USD MILLION) 40
TABLE 11 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR BLOOD PRESSURE LOWERING DRUGS, BY REGION,
2016–2025 (USD MILLION) 41
TABLE 12 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR GLUCOSE REGULATING DRUGS, BY REGION, 2016–2025 (USD MILLION) 41
TABLE 13 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR BLOOD CLOT PREVENTING DRUGS, BY REGION,
2016–2025 (USD MILLION) 42
TABLE 14 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 44
TABLE 15 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2016–2025 (USD MILLION) 45
TABLE 16 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR AMBULATORY SURGERY CENTERS, BY END USER,
2016–2025 (USD MILLION) 45
TABLE 17 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 47
TABLE 18 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 48
TABLE 19 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 48
TABLE 20 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 49
TABLE 21 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 49
TABLE 22 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 50
TABLE 23 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 51
TABLE 24 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 51
TABLE 25 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 52
TABLE 26 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 52
TABLE 27 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 53
TABLE 28 US: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 53
TABLE 29 US: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 54
TABLE 30 US: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 54
TABLE 31 US: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 55
TABLE 32 CANADA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 55
TABLE 33 CANADA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 56
TABLE 34 CANADA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 56
TABLE 35 CANADA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 57
TABLE 36 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 57
TABLE 37 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 58
TABLE 38 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 58
TABLE 39 LATIN AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 59
TABLE 40 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 60
TABLE 41 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 60
TABLE 42 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 61
TABLE 43 EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 61
TABLE 44 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 62
TABLE 45 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 63
TABLE 46 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 64
TABLE 47 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 64
TABLE 48 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 65
TABLE 49 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 65
TABLE 50 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 66
TABLE 51 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 66
TABLE 52 GERMANY: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 67
TABLE 53 GERMANY: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 67
TABLE 54 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 68
TABLE 55 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 68
TABLE 56 FRANCE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 69
TABLE 57 FRANCE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 69
TABLE 58 UK: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 70
TABLE 59 UK: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 70
TABLE 60 UK: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 71
TABLE 61 UK: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 71
TABLE 62 ITALY: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 72
TABLE 63 ITALY: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 72
TABLE 64 ITALY: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 73
TABLE 65 ITALY: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 73
TABLE 66 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 74
TABLE 67 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 74
TABLE 68 SPAIN: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 75
TABLE 69 SPAIN: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 75
TABLE 70 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 76
TABLE 71 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 76
TABLE 72 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 77
TABLE 73 REST OF WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 77
TABLE 74 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 78
TABLE 75 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 78
TABLE 76 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 79
TABLE 77 EASTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 79
TABLE 78 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 81
TABLE 79 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 81
TABLE 80 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 82
TABLE 81 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 82
TABLE 82 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 83
TABLE 83 CHINA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 83
TABLE 84 CHINA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 84
TABLE 85 CHINA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 84
TABLE 86 CHINA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 85
TABLE 87 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 85
TABLE 88 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 86
TABLE 89 JAPAN: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 86
TABLE 90 JAPAN: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 87
TABLE 91 INDIA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 87
TABLE 92 INDIA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 88
TABLE 93 INDIA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 88
TABLE 94 INDIA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 89
TABLE 95 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 89
TABLE 96 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 90
TABLE 97 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 90
TABLE 98 AUSTRALIA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 91
TABLE 99 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 91
TABLE 100 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 92
TABLE 101 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 92
TABLE 102 SOUTH KOREA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 93
TABLE 103 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 93
TABLE 104 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 94
TABLE 105 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 94
TABLE 106 REST OF ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 95
TABLE 107 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2016–2025 (USD MILLION) 96
TABLE 108 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 97
TABLE 109 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 97
TABLE 110 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 98
TABLE 111 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 98
TABLE 112 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 99
TABLE 113 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 99
TABLE 114 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 100
TABLE 115 MIDDLE EAST: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 100
TABLE 116 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2016–2025 (USD MILLION) 101
TABLE 117 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, FOR DEVICES, BY TYPE, 2016–2025 (USD MILLION) 101
TABLE 118 AFRICA: PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2016–2025 (USD MILLION) 102
TABLE 119 AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2016–2025 (USD MILLION) 102
TABLE 120 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 106
TABLE 121 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 106
TABLE 122 B. BRAUN MELSUNGEN AG: PRODUCTS/SERVICES OFFERED 109
TABLE 123 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENTS 110
TABLE 124 COOK: PRODUCTS/SERVICES OFFERED 111
TABLE 125 COOK: KEY DEVELOPMENTS 111
TABLE 126 MEDTRONIC: PRODUCTS/SERVICES OFFERED 115
TABLE 127 KEY DEVELOPMENTS 115
TABLE 128 BAYER AG: PRODUCTS/SERVICES OFFERED 118
TABLE 129 BAYER AG: KEY DEVELOPMENTS 119
TABLE 130 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 122
TABLE 131 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 125
TABLE 132 BECTON, DICKINSON AND COMPANY: KEY DEVELOPMENTS 126
TABLE 133 TERUMO MEDICAL CORPORATION: PRODUCTS OFFERED 128
TABLE 134 TERUMO MEDICAL CORPORATION: KEY DEVELOPMENTS 129
TABLE 135 BIOTRONIK: PRODUCTS OFFERED 130
TABLE 136 BIOTRONIK: KEY DEVELOPMENTS 131
TABLE 137 CARDINAL HEALTH: PRODUCTS OFFERED 135
TABLE 138 CARDINAL HEALTH: KEY DEVELOPMENTS 135


LIST OF FIGURES
FIGURE 1 GLOBAL PERIPHERAL ARTERY DISEASE MARKET STRUCTURE 17
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 23
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERIPHERAL ARTERY DISEASE MARKET 25
FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PERIPHERAL ARTERY DISEASE MARKET 29
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL PERIPHERAL ARTERY DISEASE MARKET 31
FIGURE 6 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY TREATMENT TYPE, 2018 (%) 33
FIGURE 7 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TREATMENT TYPE, 2018 AND 2025 (USD MILLION) 34
FIGURE 8 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DEVICES, BY TYPE, 2018 AND 2025 (USD MILLION) 35
FIGURE 9 GLOBAL PERIPHERAL ARTERY DISEASE MARKET FOR DRUGS, BY TYPE, 2018 AND 2025 (USD MILLION) 39
FIGURE 10 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY END USER, 2018 (%) 43
FIGURE 11 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY END USER, 2018 AND 2025 (USD MILLION) 44
FIGURE 12 GLOBAL PERIPHERAL ARTERY DISEASE MARKET SHARE, BY REGION, 2018 (%) 46
FIGURE 13 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 46
FIGURE 14 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 47
FIGURE 15 AMERICAS: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 48
FIGURE 16 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 50
FIGURE 17 NORTH AMERICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 51
FIGURE 18 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 59
FIGURE 19 EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 60
FIGURE 20 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 62
FIGURE 21 WESTERN EUROPE: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 63
FIGURE 22 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 80
FIGURE 23 ASIA-PACIFIC: PERIPHERAL ARTERY DISEASE MARKET, BY COUNTRY, 2018 AND 2025 (USD MILLION) 80
FIGURE 24 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 95
FIGURE 25 MIDDLE EAST & AFRICA: PERIPHERAL ARTERY DISEASE MARKET, BY REGION, 2018 AND 2025 (USD MILLION) 96
FIGURE 26 GLOBAL: MARKET SHARE OF MAJIOUR COMPETITORS, 2018 (%) 103
FIGURE 27 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 105
FIGURE 28 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 107
FIGURE 29 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW 109
FIGURE 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 110
FIGURE 31 COOK: SWOT ANALYSIS 112
FIGURE 32 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 114
FIGURE 33 MEDTRONIC: SWOT ANALYSIS 116
FIGURE 34 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 118
FIGURE 35 BAYER AG: SWOT ANALYSIS 119
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 121
FIGURE 37 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS 123
FIGURE 38 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT 125

FIGURE 39 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 126
FIGURE 40 TERUMO MEDICAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 128
FIGURE 41 TERUMO MEDICAL CORPORATION: SWOT ANALYSIS 129
FIGURE 42 BIOTRONIK: SWOT ANALYSIS 132
FIGURE 43 CARDIAC HEALTH: FINANCIAL OVERVIEW SNAPSHOT 134
FIGURE 44 CARDINAL HEALTH: SWOT ANALYSIS 136


【掲載企業】

Koninklijke Philips NV (Netherlands), B. Braun Melsungen AG (Germany), Cook (US), Medtronic (Ireland), Bayer AG (Germany), Boston Scientific Corporation (US), Becton, Dickinson, and Company (BD) (US), Terumo Medical Corporation (Japan ), Biotronik (Germany), Cardinal Health (US), and others

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の末梢動脈疾患市場2025]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆